Emerging Molecular Targets in the Therapy of Dialysis-Related Amyloidosis

Protein Misfolding Diseases: Current and Emerging Principles and Therapies

Volumn , Issue , 2010, Pages 843-865

  Esposito, Gennaro ^a   Bellotti, Vittorio ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Emerging molecular targets in dialysis related amyloidosis therapy; fibrillogenic environment modification and global therapeutic strategy against DRA; Selective absorption of 2m efficient removal of protein, without major losses of other important molecules

Indexed keywords

EID: 84883479663     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470572702.ch38     Document Type: Chapter

References (77)

1. Dobson, C.M. (1999). Protein misfolding, evolution and disease. Trends Biochem Sci, 24, 329-332.
2. Sunde, M., Blake, C.C. (1998). From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q Rev Biophys, 31, 1-39.
3. Chiti, F., Dobson, C.M. (2006). Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem, 75, 333-366.
4. Naiki, H., Hashimoto, N., Suzuki, S., Kimura, H., Nakakuki, K., Gejyo, F. (1997). Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro. Amyloid: Int J Exp Clin Invest, 4, 223-232.
5. Naiki, H., Yamamoto, S., Hasegawa, K., Yamaguchi, I., Goto, Y., Gejyo, F. (2005). Molecular interactions in the formation and deposition of beta2-microglobulin-related amyloid fibrils. Amyloid, 12, 15-25.
6. Serio, T.R., Cashikar, A.G., Kowal, A.S., Sawicki, G.J., Moslehi, J.J., Serpell, L., Arnsdorf, M.F., Lindquist, S.L. (2000). Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science, 289, 1317-1321.
7. Uversky, V.N., Li, J., Souillac, P., Millett, I.S., Doniach, S., Jakes, R., Goedert, M., Fink, A.L. (2002). Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta-and gamma-synucleins. J Biol Chem, 277, 11970-11978.
8. Corazza, A., Pettirossi, F., Viglino, P., Verdone, G., Garcia, J., Dumy, P., Giorgetti, S., Mangione, P., Raimondi, S., Stoppini, M., et al. (2004). Properties of some variants of human beta2-microglobulin and amyloidogenesis. J Biol Chem, 279, 9176-9189.
9. Harper, J.D., Wong, S.S., Lieber, C.M., Lansbury, P.T. (1997). Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol, 4, 119-125.
10. Walsh, D.M., Lomakin, A., Benedek, G.B., Condron, M.M., Teplow, D.B. (1997). Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem, 272, 22364-22372.
11. Ionescu-Zanetti, C., Khurana, R., Gillespie, J.R., Petrick, J.S., Trabachino, L.C., Minert, L.J., Carter, S.A., Fink, A.L. (1999). Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy. Proc Natl Acad Sci U S A, 96, 13175-13179.
12. Quintas, A., Vaz, D.C., Cardoso, I., Saraiva, M.J., Brito, R.M. (2001). Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem, 276, 27207-27213.
13. Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T.M., Milton, S.C., Hall, J.E., Glabe, C.G. (2004). Permeabilization of lipid bilayers is a common conformationdependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem, 279, 46363-46366.
14. Borysik, A.J., Radford, S.E., Ashcroft, A.E. (2004). Co-populated conformational ensembles of beta2-microglobulin uncovered quantitatively by electrospray ionization mass spectrometry. J Biol Chem, 279, 27069-27077.
15. Smith, A.M., Jahn, T.R., Ashcroft, A.E., Radford, S.E. (2006). Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry. J Mol Biol, 364, 9-19.
16. Pande, V.S., Grosberg, A., Tanaka, T., Rokhsar, D.S. (1998). Pathways for protein folding: Is a new view needed? Curr Opin Struct Biol, 8, 68-79.
17. Dobson, C.M., Karplus, M. (1999). The fundamentals of protein folding: bringing together theory and experiment. Curr Opin Struct Biol, 9, 92-101.
18. Esposito, G., Corazza, A., Viglino, P., Verdone, G., Pettirossi, F., Fogolari, F., Makek, A., Giorgetti, S., Mangione, P., Stoppini, M., Bellotti, V. (2005). Solution structure of beta(2)-microglobulin and insights into fibrillogenesis. Biochim Biophys Acta, 1753, 76-84.
19. Plakoutsi, G., Bemporad, F., Calamai, M., Taddei, N., Dobson, C.M., Chiti, F. (2005). Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J Mol Biol, 351, 910-922.
20. Bjorkman, P.J., Saper, M.A., Samraoui, B., Bennett, W.S., Strominger, J.L., Wiley, D.C. (1987). Structure of the human class I histocompatibility antigen, HLA-A2. Nature, 329, 506-512.
21. Gejyo, F., Yamada, T., Odani, S., Nakagawa, Y., Arakawa, M., Kunitomo, T., Kataoka, H., Suzuki, M., Hirasawa, Y., Shirahama, T., et al. (1985). A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun, 129, 701-706.
22. Faull, R.J. (2007). Managing bone parameters in dialysis patients: international guideline conflicts. Semin Dial, 20, 191-194.
23. Cases, A. (2007). The latest advances in kidney diseases and related disorders. Drug News Perspect, 20, 647-654.
24. Schwalbe, S., Holzhauer, M., Schaeffer, J., Galanski, M., Koch, K.M., Floege, J. (1997). Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis? Kidney Int, 52, 1077-1083.
25. European Best Practices Guidelines Expert Group on Hemodialysis ERA. (2002). Haemodialysis adequacy. Nephrol Dial Transplant, Suppl 7, 16-31.
26. van Ypersele de Strihou, C., Jadoul, M., Malghem, J., Maldague, B., Jamart, J. (1991). Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. Kidney Int, 39, 1012-1019.
27. Krieter, D.H., Lemke, H.D., Canaud, B., Wanner, C. (2005). Beta(2)-microglobulin removal by extracorporeal renal replacement therapies. Biochim Biophys Acta, 1753, 146-153.
28. Kramer, B.K., Pickert, A., Hohmann, C., Liebich, H.M., Muller, G.A., Hablitzel, M., Risler, T. (1992). In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes. Int J Artif Organs, 15, 408-412.
29. Leber, H.W., Wizemann, V., Goubeaud, G., Rawer, P., Schutterle, G. (1978). Hemodiafiltration: a new alternative to hemofiltration and conventional hemodialysis. Artif Organs, 2, 150-153.
30. Gejyo, F., Kawaguchi, Y., Hara, S., Nakazawa, R., Azuma, N., Ogawa, H., Koda, Y., Suzuki, M., Kaneda, H., Kishimoto, H., et al. (2004). Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column. Artif Organs, 28, 371-380.
31. Linke, R.P., Hampl, H., Bartel-Schwarze, S., Eulitz, M. (1987). Beta 2-microglobulin, different fragments and polymers thereof in synovial amyloid in long-term hemodialysis. Biol Chem Hoppe Seyler, 368, 137-144.
32. Linke, R.P., Hampl, H., Lobeck, H., Ritz, E., Bommer, J., Waldherr, R., Eulitz, M. (1989). Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int, 36, 675-681.
33. Bellotti, V., Stoppini, M., Mangione, P., Sunde, M., Robinson, C., Asti, L., Brancaccio, D., Ferri, G. (1998). Beta2-microglobulin can be refolded into a native state from ex vivo amyloid fibrils. Eur J Biochem, 258, 61-67.
34. Miyata, T., Oda, O., Inagi, R., Iida, Y., Araki, N., Yamada, N., Horiuchi, S., Taniguchi, N., Maeda, K., Kinoshita, T. (1993). Beta 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest, 92, 1243-1252.
35. Capeillere-Blandin, C., Delaveau, T., Descamps-Latscha, B. (1991). Structural modifications of human beta 2 microglobulin treated with oxygen-derived radicals. Biochem J, 277 (Pt 1), 175-182.
36. Pepys, M.B., Booth, D.R., Hutchinson, W.L., Gallimore, J.R., Collins, P.M., Hohenester, E. (1997). Amyloid P component: a critical review. Amyloid: Int J Exp Clin Invest, 4, 274-295.
37. Esposito,G., Michelutti,R., Verdone, G.,Viglino, P.,Hernandez,H.,Robinson, C.V., Amoresano, A., Dal Piaz, F., Monti, M., Pucci, P., et al. (2000). Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci, 9, 831-845.
38. Monti, M., Principe, S., Giorgetti, S.,Mangione, P., Merlini, G., Clark, A., Bellotti, V., Amoresano, A., Pucci, P. (2002). Topological investigation of amyloid fibrils obtained from beta2-microglobulin. Protein Sci, 11, 2362-2369.
39. Hoshino, M., Katou, H., Hagihara, Y., Hasegawa, K., Naiki, H., Goto, Y. (2002). Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nat Struct Biol, 9, 332-336.
40. McParland, V.J., Kalverda, A.P., Homans, S.W., Radford, S.E. (2002). Structural properties of an amyloid precursor of beta(2)-microglobulin. Nat Struct Biol, 9, 326-331.
41. Verdone, G., Corazza, A., Viglino, P., Pettirossi, F., Giorgetti, S., Mangione, P., Andreola, A., Stoppini, M., Bellotti, V., Esposito, G. (2002). The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition. Protein Sci, 11, 487-499.
42. Morgan, C.J., Gelfand, M., Atreya, C., Miranker, A.D. (2001). Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation. J Mol Biol, 309, 339-345.
43. Villanueva, J.,Hoshino, M., Katou, H., Kardos, J., Hasegawa, K., Naiki, H., Goto,Y. (2004). Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis. Protein Sci, 13, 797-809.
44. Rosano, C., Zuccotti, S., Mangione, P., Giorgetti, S., Bellotti, V., Pettirossi, F., Corazza, A., Viglino, P., Esposito, G., Bolognesi, M. (2004). Beta2-microglobulin H31Y variant 3D structure highlights the protein natural propensity towards intermolecular aggregation. J Mol Biol, 335, 1051-1064.
45. Chiti, F., Mangione, P., Andreola, A., Giorgetti, S., Stefani, M., Dobson, C.M., Bellotti, V., Taddei, N. (2001). Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin. J Mol Biol, 307, 379-391.
46. Chiti, F., De Lorenzi, E., Grossi, S., Mangione, P., Giorgetti, S., Caccialanza, G., Dobson, C.M., Merlini, G., Ramponi, G., Bellotti, V. (2001). A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. J Biol Chem, 276, 46714-46721.
47. Kameda, A., Hoshino, M., Higurashi, T., Takahashi, S., Naiki, H., Goto, Y. (2005). Nuclear magnetic resonance characterization of the refolding intermediate of beta 2-microglobulin trapped by non-native prolyl peptide bond. J Mol Biol, 348, 383-397.
48. Jahn, T.R., Parker, M.J., Homans, S.W., Radford, S.E. (2006). Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat Struct Mol Biol, 13, 195-201.
49. Yamaguchi, K., Takahashi, S., Kawai, T., Naiki, H., Goto, Y. (2005). Seedingdependent propagation and maturation of amyloid fibril conformation. J Mol Biol, 352, 952-960.
50. Chatani, E., Goto, Y. (2005). Structural stability of amyloid fibrils of beta(2)-microglobulin in comparison with its native fold. Biochim Biophys Acta, 1753, 64-75.
51. Yamamoto, S., Hasegawa, K., Yamaguchi, I., Tsutsumi, S., Kardos, J., Goto, Y., Gejyo, F., Naiki, H. (2004). Low concentrations of sodium dodecyl sulfate induce the extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry, 43, 11075-11082.
52. Yamamoto, S., Yamaguchi, I., Hasegawa, K., Tsutsumi, S., Goto, Y., Gejyo, F., Naiki, H. (2004). Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. J Am Soc Nephrol, 15, 126-133.
53. Myers, S.L., Jones, S., Jahn, T.R., Morten, I.J., Tennent, G.A., Hewitt, E.W., Radford, S.E. (2006). A systematic study of the effect of physiological factors on beta2-microglobulin amyloid formation at neutral pH. Biochemistry, 45, 2311-2321.
54. Piazza, R., Pierno, M., Iacopini, S., Mangione, P., Esposito, G., Bellotti, V. (2006). Micro-heterogeneity and aggregation in beta2-microglobulin solutions: effects of temperature, pH, and conformational variant addition. Eur Biophys J, 35, 439-445.
55. Giorgetti, S., Rossi, A., Mangione, P., Raimondi, S., Marini, S., Stoppini, M., Corazza, A., Viglino, P., Esposito, G., Cetta, G., et al. (2005). Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. Protein Sci, 14, 696-702.
56. Relini, A., Canale, C., De Stefano, S., Rolandi, R., Giorgetti, S., Stoppini, M., Rossi, A., Fogolari, F., Corazza, A., Esposito, G., et al. (2006). Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis. J Biol Chem, 281, 16521-16529.
57. Fogolari, F., Corazza, A., Viglino, P., Zuccato, P., Pieri, L., Faccioli, P., Bellotti, V., Esposito, G. (2007). Molecular dynamics simulation suggests possible interaction patterns at early steps of beta2-microglobulin aggregation. Biophys J, 92, 1673-1681.
58. Kihara, M., Chatani, E., Iwata, K., Yamamoto, K., Matsuura, T., Nakagawa, A., Naiki, H., Goto, Y. (2006). Conformation of amyloid fibrils of beta2-microglobulin probed by tryptophan mutagenesis. J Biol Chem, 281, 31061-31069.
59. Esposito, G., Ricagno, S., Corazza, A., Rennella, E., Gumral, D., Mimmi, M.C., Betto, E., Pucillo, C.E., Fogolari, F., Viglino, P., et al. (2008). The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. J Mol Biol, 378, 885-895.
60. Trinh, C.H., Smith, D.P., Kalverda, A.P., Phillips, S.E., Radford, S.E. (2002). Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties. Proc Natl Acad Sci U S A, 99, 9771-9776.
61. Mimmi, M.C., Jorgensen, T.J., Pettirossi, F., Corazza, A., Viglino, P., Esposito, G., De Lorenzi, E., Giorgetti, S., Pries, M., Corlin, D.B., et al. (2006). Variants of beta-microglobulin cleaved at lysine-58 retain the main conformational features of the native protein but are more conformationally heterogeneous and unstable at physiological temperature. FEBS J, 273, 2461-2474.
62. Richardson, J.S., Richardson, D.C. (2002). Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci U S A, 99, 2754-2759.
63. Homma, N., Gejyo, F., Isemura, M., Arakawa, M. (1989). Collagen-binding affinity of beta-2-microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron, 53, 37-40.
64. Linke, R.P., Bommer, J., Ritz, E., Waldherr, R., Eulitz, M. (1986). Amyloid kidney stones of uremic patients consist of beta 2-microglobulin fragments. Biochem Biophys Res Commun, 136, 665-671.
65. Relini, A., De Stefano, S., Torrassa, S., Cavalleri, O., Rolandi, R., Gliozzi, A., Giorgetti, S., Raimondi, S., Marchese, L., Verga, L., et al. (2008). Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen. J Biol Chem, 283, 4912-4920,
66. Lindahl, U. (2007). Heparan sulfate-protein interactions: a concept for drug design? Thromb Haemost, 98, 109-115.
67. Kisilevsky, R. (2000). Review: amyloidogenesis-unquestioned answers and unanswered questions. J Struct Biol, 130, 99-108.
68. Ohashi, K., Kisilevsky, R., Yanagishita, M. (2002). Affinity binding of glycosaminoglycans with beta(2)-microglobulin. Nephron, 90, 158-168.
69. McLaurin, J., Franklin, T., Zhang, X., Deng, J., Fraser, P.E. (1999). Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. Eur J Biochem, 266, 1101-1110.
70. Castillo, G.M., Lukito, W., Wight, T.N., Snow, A.D. (1999). The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. J Neurochem, 72, 1681-1687.
71. Cohlberg, J.A., Li, J., Uversky, V.N., Fink, A.L. (2002). Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. Biochemistry, 41, 1502-1511.
72. Suk, J.Y., Zhang, F., Balch, W.E., Linhardt, R.J., Kelly, J.W. (2006). Heparin accelerates gelsolin amyloidogenesis. Biochemistry, 45, 2234-2242.
73. Snow, A.D., Kisilevsky, R. (1985). Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis: a histochemical study. Lab Invest, 53, 37-44.
74. Li, J.P., Galvis, M.L., Gong, F., Zhang, X., Zacharia, E., Metzger, S., Vlodavsky, I., Kisilevsky, R., Lindahl, U. (2005). In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. Proc Natl Acad Sci U S A, 102, 6473-6477.
75. Kisilevsky, R., Lemieux, L.J., Fraser, P.E., Kong, X., Hultin, P.G., Szarek, W.A. (1995). Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med, 1, 143-148.
76. Evenepoel, P., Dejagere, T., Verhamme, P., Claes, K., Kuypers, D., Bammens, B., Vanrenterghem, Y. (2007). Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. Am J Kidney Dis, 49, 642-649.
77. Calamai, M., Kumita, J.R., Mifsud, J., Parrini, C., Ramazzotti, M., Ramponi, G., Taddei, N., Chiti, F., Dobson, C.M. (2006). Nature and significance of the interactions between amyloid fibrils and biological polyelectrolytes. Biochemistry, 45, 12806-12815.